GI
SNOA icon

Gradient Investments’s Sonoma Pharmaceuticals SNOA Stock Holding History

Gradient Investments’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$33 – 1902
2023
Q2 		$33 Hold
2
– – ﹤0.01% 1727
2023
Q1 		$30 Hold
2
– – ﹤0.01% 1485
2022
Q4 		$35 Hold
2
– – ﹤0.01% 1465
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1524
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1365
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1325
2021
Q4 		$0 Hold
2
– – ﹤0.01% 1320
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1242
2021
Q2 		$0 Hold
2
– – ﹤0.01% 1250
2021
Q1 		$0 Hold
2
– – ﹤0.01% 1272
2020
Q4 		$0 Hold
2
– – ﹤0.01% 1172
2020
Q3 		$0 Hold
2
– – ﹤0.01% 1215
2020
Q2 		$0 Hold
2
– – ﹤0.01% 1185
2020
Q1 		$0 Hold
2
– – ﹤0.01% 1226
2019
Q4 		$0 Hold
2
– – ﹤0.01% 1219
2019
Q3 		$0 Hold
2
– – ﹤0.01% 1221
2019
Q2 		$0 Hold
2
– – ﹤0.01% 1077
2019
Q1 		$0 Hold
2
– – ﹤0.01% 994
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1073
2018
Q3 		$0 Hold
2
– – ﹤0.01% 1049
2018
Q2 		$1K Hold
2
– – ﹤0.01% 928
2018
Q1 		$1K Buy
+2
New +$1.64K ﹤0.01% 941

Other funds holding SNOA

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Gradient Investments's SNOA Position: Q3 2023 in Review

Gradient Investments sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2023, closing a stake of 2 shares — an estimated $33 sold.

Gradient Investments first reported a position in SNOA in Q1 2018 and held it in 22 quarters. The position peaked at $1K in Q2 2018. 12 funds tracked by Wall St. Rank hold SNOA as of Q3 2023.

  • Gradient Investments reported no remaining Sonoma Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Gradient Investments sold 2 Sonoma Pharmaceuticals shares in Q3 2023, an estimated $33.
  • Gradient Investments first reported a position in Sonoma Pharmaceuticals in Q1 2018 and held it in 22 quarters.
  • Gradient Investments's Sonoma Pharmaceuticals position peaked at $1K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2023.

Based on Gradient Investments's 13F filing for Q3 2023, filed 27 Oct 2023.